Cargando…
Exclusion of Patients with Autoimmune Disease in Lung Cancer Clinical Trials
BACKGROUND: The exclusion of patients with autoimmune disease has been a topic of cancer immunotherapy trial. This study aims to find recent trends in exclusion of autoimmune disease. METHODS: Using the website clinicaltrials.gov, we searched for clinical trials that were initiated in 2012 or later...
Autores principales: | Khan, Shamsher S, Komiya, Takefumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152841/ https://www.ncbi.nlm.nih.gov/pubmed/36708584 http://dx.doi.org/10.31557/APJCP.2023.24.1.331 |
Ejemplares similares
-
An Overview of Lung and Breast Cancer Using the National Cancer Database
por: Deshotels, Leigh, et al.
Publicado: (2020) -
Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer
por: Takamori, Shinkichi, et al.
Publicado: (2022) -
Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case Series
por: Dasari, Srikiran, et al.
Publicado: (2022) -
Survival benefit from immunocheckpoint inhibitors in stage IV non‐small cell lung cancer patients with brain metastases: A National Cancer Database propensity‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2020) -
Systematic analysis of design and stratification for phase III trials in first‐line advanced non‐small cell lung cancer
por: Komiya, Takefumi, et al.
Publicado: (2015)